PAR paradigm biopharmaceuticals limited..

PAR and the Possible Sales Projection, page-5

  1. 2,427 Posts.
    lightbulb Created with Sketch. 293
    Thanks for the reminder Happell Probably best to keep a balanced outlook. I'll try...

    It's very hard with PAR to keep the bias getting out of control. But then I think is it bias or is it just that the fundamentals of this business justify a very positive outlook. This stock has got me like no other.

    We have a pretty rock solid leadership with big pharma experience. I feel they will be able to guide us through to a big pharma partnership. The potential is far too great to let a takeover occur. They have been in partnership discussions for a while now, it's all about timing to get the best deal.

    DYOR

    PharmD
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.0¢
Change
0.005(1.20%)
Mkt cap ! $166.9M
Open High Low Value Volume
42.0¢ 43.0¢ 42.0¢ $117.7K 277.1K

Buyers (Bids)

No. Vol. Price($)
2 13178 42.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.5¢ 17422 2
View Market Depth
Last trade - 16.10pm 14/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.